CTRI/2012/01/002333招募中未知
Pilot Study to Evaluate Dose Dense Vincristine, Etoposide, Carboplatin (VEC) Chemotherapy and Intrathecal Prophylaxis in IRSS Stage III Retinoblastoma
ALL INDIA INSTITUTE OF MEDICAL SCIENCES AIIMS0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Untreated consecutive IRSS stage III retinoblastoma patients will be included in the present study.
排除标准
- •1.Metastatic disease at baseline
- •2.Relapsed retinoblastoma in the same eye
- •3.Received previous chemotherapy for retinoblastoma
- •4.Upfront enucleation or exenteration of the involved eye
- •5.Does not consent to participate in the study
研究者
相似试验
已完成
1 期
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginRefractory Solid Tumors in ChildrenNCT00993044Children's Hospital Los Angeles13
进行中（未招募）
不适用
Vincristine Pharmacokinetics in InfantsHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmNCT05359237Children's Oncology Group83
终止
2 期
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple MyelomaMultiple MyelomaNCT00441168Janssen-Cilag International NV30
已完成
3 期
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaL1 Childhood Acute Lymphoblastic LeukemiaL2 Childhood Acute Lymphoblastic LeukemiaIntermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaNCT00381680Children's Oncology Group275
已完成
2 期
Research Study in Patients With Severe Ulcerative ColitisUlcerative ColitisNCT00032305Facet Biotech20